Evidence map›Paper›PMID 23269742›Full record

ArticleJournal of clinical microbiology2013

Changes in molecular epidemiology of streptococcus pneumoniae causing meningitis following introduction of pneumococcal conjugate vaccination in England and Wales.

Bruno Pichon, Shamez N Ladhani, Mary P E Slack, Anne Segonds-Pichon, Nick J Andrews, Pauline A Waight, Elizabeth Miller, Robert George

Abstract read
In one paragraph

Article in Journal of clinical microbiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Molecular Epidemiology ofInternational journal of molecular sciences · 2025
    Pooled it
  3. Trial
  4. Article
  5. Article
  6. Epidemiology of non-vaccine serotypes ofHuman vaccines & immunotherapeutics · 2021
    Review
  7. Article
  8. Article
  9. Pneumococcal Vaccines.Microbiology spectrum · 2019
    Review
  10. Article
  11. Article
  12. Blood‒Brain Barrier Pathology and CNS Outcomes inInternational journal of molecular sciences · 2018
    Review
  13. Article
  14. Article
  15. Antigenic Variation and Immune Escape in the MTBC.Advances in experimental medicine and biology · 2017
    Review
  16. Article
  17. Article
  18. Article
  19. Development and evaluation of MALDI-TOF MS-based serotyping for Streptococcus pneumoniae.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2015
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Bruno PichonRespiratory and Systemic Infection Laboratory, Health Protection Agency, London, United Kingdom.
Shamez N Ladhani
Mary P E Slack
Anne Segonds-Pichon
Nick J Andrews
Pauline A Waight
Elizabeth Miller
Robert George

Funding

Department of Health
6 · The paper itself

Abstract

The introduction of the 7-valent pneumococcal conjugate vaccine (PCV7) in September 2006 has markedly reduced the burden of invasive pneumococcal disease (IPD) including meningitis in England and Wales. This study examined changes in the molecular epidemiology of pneumococcal isolates causing meningitis from July 2004 to June 2009. The Health Protection Agency conducts enhanced pneumococcal surveillance in England and Wales. In addition to serotyping, pneumococcal isolates causing meningitis were genotyped by multilocus sequence typing (MLST). A total of 1,030 isolates were both serotyped and genotyped over the 5-year period. Fifty-two serotypes, 238 sequence types (STs), and 87 clonal complexes were identified, with no significant difference in the yearly Simpson's diversity index values (range, 0.974 to 0.984). STs commonly associated with PCV7 serotypes declined following PCV implementation, with a proportionally greater decline in ST124 (commonly associated with serotype 14). No other ST showed significant changes in distribution, even within individual serotypes. Replacement disease following PCV7 introduction was mainly due to serotypes 1, 3, 7F, 19A, 22F, and 33F through clonal expansion. A single instance of possible capsule switching was identified where one ST4327 clone expressed a serotype 14 capsule in 2005 and a serotype 28A capsule in 2009. In 2008 to 2009, ST191 (7F) became the most prevalent clone causing meningitis (10.3%). Case fatality (145 fatalities/1,030 cases; 14.1%) was high across all age groups and serotype groups. Thus, the introduction of PCV7 resulted in an increase in non-PCV7 serotypes, including some not covered by the 13-valent vaccine, such as serotypes 22F and 33F, emphasizing the importance of long-term epidemiological and molecular surveillance.

Indexed as

AdolescentAdultAgedAged, 80 and overChildChild, PreschoolEnglandFemaleGenotypeHeptavalent Pneumococcal Conjugate VaccineHumansInfantInfant, NewbornMaleMeningitis, PneumococcalMiddle AgedHeptavalent Pneumococcal Conjugate VaccinePneumococcal Vaccines

Identifiers

PMID23269742
PMCPMC3592052

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.